Hypoxia-inducible factor-1α is involved in the attenuation of experimentally induced rat glomerulonephritis

Nephron - Experimental Nephrology

Volumn 100, Issue 2, 2005, Pages

  Kudo, Yoshihiro ^a   Kakinuma, Yoshihiko ^a   Mori, Yasukiyo ^b   Morimoto, Norihito ^a   Karashima, Takashi ^a   Furihata, Mutsuo ^a   Sato, Takayuki ^a   Shuin, Taro ^a   Sugiura, Tetsuro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Glomerulonephritis; Habu snake venom; Hypoxia inducible factor 1

Indexed keywords

ANGIOTENSIN; COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EXPERIMENTAL MODEL; GLOMERULONEPHRITIS; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION;

ANGIOTENSIN II; ANIMALS; CELL SURVIVAL; CROTALID VENOMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; RATS; RATS, WISTAR; TRIMERESURUS;

EID: 20944446740     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084575     Document Type: Article

References (33)

1. Rifai A, Small PA Jr, Teague PO, Ayoub EM: Experimental IgA nephropathy. J Exp Med 1979;150:1161-1173.
2. Ishizaki M, Masuda Y, Fukuda Y, Yamanaka N, Masugi Y, Shichinohe K, Nakama K: Renal lesions in a strain of spontaneously diabetic WBN/Kob rats. Acta Diabetol Lat 1987;24:27-35.
3. Banks KL: Glomerulonephritis, autoimmunity, autoantibody. Animal model: Anti-glomerular basement membrane antibody in horses. Am J Pathol 1979;94:443-446.
4. Elzinga LW, Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 1993;4:214-221.
5. Arendshorst WJ, Finn WF, Gottschalk CW: Pathogenesis of acute renal failure following temporary renal ischemia in the rat. Circ Res 1975;37:558-568.
6. Wilson CB, Dixon FJ: Immunopathologic mechanisms of renal disease. Ric Clin Lab 1975;5:17-38.
7. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001;159:599-608.
8. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
9. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995;96:953-964.
10. Huang LE, Arany Z, Livingston DM, Bunn HF: Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996;271:32253-32259.
11. 2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
12. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002;13:1721-1732.
13. Wenger RH, Rolfs A, Marti HH, Guenet JL, Gassmann M: Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochem Biophys Res Commun 1996;223:54-59.
14. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000;275:26765-26771.
15. Page EL, Robitaille GA, Pouyssegur J, Richard DE: Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002;277:48403-48409.
16. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-143.
17. Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE: Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol 1988;255:F728-F735.
18. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E: Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999;55:945-955.
19. Kaneko Y, Shiozawa S, Hora K, Nakazawa K: Glomerulosclerosis develops in Thy-1 nephritis under persistent accumulation of macrophages. Pathol Int 2003;53:507-517.
20. Barnes JL, Lisa MS: Origin of interstitial fibroblasts in an accelerated model of angiotensin II (AII)-induced interstitial fibrosis. J Am Soc Nephrol 2001;12:699A3645.
21. Cattell V, Bradfield JW: Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study. Am J Pathol 1977;87:511-524.
22. Kitamura H, Sugisaki Y, Yamanaka N: Endothelial regeneration during the repair process following Habu-snake venom induced glomerular injury. Virchows Arch 1995;427:195-204.
23. Ruggenenti P: Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Semin Nephrol 2004;24:158-167.
24. Tolins JP, Raij L: Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension 1991;17:1045-1051.
25. Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999;55:877-889.
26. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L: Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001;414:550-554.
27. Neckers LM: aHIF: The missing link between HIF-1 and VHL? J Natl Cancer Inst 1999;91:106-107.
28. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-275.
29. Zhou J, Fandrey J, Schumann J, Tiegs G, Brune B: NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Am J Physiol Cell Physiol 2003;284:C439-C446.
30. Sandau KB, Zhou J, Kietzmann T, Brune B: Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 2001;276:39805-39811.
31. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, Scharff A, Dirnagl U, Meisel A: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 2002;22:520-525.
32. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP: Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001;193:1027-1034.
33. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003;14:1825-1832.